Novartis’ Blockbuster Hopeful Leqvio Faces Perils Of Medicare’s Pricing Policy On Small Molecules

 
• By Cathy Kelly
  
Biopharma Companies Evaluating The Challenges Ahead In Medicare • Source: Shutterstock
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access